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OxLDL uptake and cholesterol eﬄux inhibition in macrophages play a key role in atherosclerotic plaque formation, rupture,
and thrombotic ischemia. This study investigates genes implicated in OxLDL uptake (CD36, SRA), cholesterol eﬄux inhibition
(adipophilin, ADFP), and inﬂammatory recruitments of leukocytes (IL-8) in plaque lesion areas (PLAs) compared to nonplaque
lesion areas (NPLAs) in human carotid endarterectomy specimens. Gene and protein expressions were assayed using quantitative
PCR and quantitative immunohistochemistry. Pearson tests were used to investigate potential correlation between (a) diﬀerent
gene expressions and (b) gene expression and patient’s plasma constituents. CD36, SRA, ADFP, and IL-8 were shown to be
signiﬁcantly more expressed in PLA compared to NPLA. In PLA, a signiﬁcant correlation was observed between CD36, SRA,
ADFP, and IL-8 mRNA levels. Moreover, CD36 expression level was signiﬁcantly inversely correlated to plasma marker ApoAI.
The above investigated genes/proteins may play a key role in the maturation of atherosclerotic lesions.
Copyright © 2008 Sophie Collot-Teixeira et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Macrophage uptake of oxidised low density lipoprotein
(OxLDL) and the concomitant reduction in cholesterol
eﬄux are thought to play a critical role in atherosclerotic
plaque formation and subsequent rupture. A number of
macrophage OxLDL receptors have been identiﬁed (e.g.,
CD36, SRBI, SRA) [1, 2] but two in particular, CD36 and
SRA, have been shown to be responsible for up to 90%
of OxLDL uptake and degradation by macrophages [3]. A
double knockout mouse model of atherosclerosis (ApoE
−/−,
CD36
−/−) has many fewer and smaller lesions compared to
ApoE
−/− animals that express CD36, even after long-term
feeding with a western diet, [4, 5] which indicates that the
CD36 scavenger receptor is implicated in the generation of
advancedplaques.Thisis,however,atvariancewiththeﬁnd-
ing that similar double knockout mice have a comparable,
or even increased, atherosclerotic lesions in the region of the
aortic valve [6] as the ApoE
−/− m i c et h a th a v ei n t a c tC D 3 6 ,
indicating that uptake and endocytosis of OxLDL seem to be
independent of CD36 [6]. Diﬀerent possibilities have been
recently reviewed to explain such discrepancies [7, 8]. Fur-
thermore, results from ApoE
−/− mice have to be interpreted
cautiously, as the lesions are diﬀerent from those observed
in humans, often with none of the clinical end points, such
as thrombotic ischaemia, resulting in myocardial infarction
or stroke [9]. The present work has attempted to overcome
this limitation by examining human carotid endarterectomy
specimens. Indeed, very few studies have investigated the
expression of CD36 in human vascular lesions [10].2 Journal of Biomedicine and Biotechnology
Adipophilin (ADFP), a cellular indicator of the amount
of stored lipids, is present in a very large number of tissues
[11]. Increased expression of ADFP in THP-1 monocytic
cell line has been observed to induce cholesterol storage and
reduction of cholesterol eﬄux [12]. Moreover, its expression
in macrophages has been correlated with the presence of
red blood cells and cholesterol crystals in vascular lesions
[13]. Finally, ADFP may play a role in the diﬀerentiation of
macrophages into foam cells [14].
High density lipoproteins (HDLs) are implicated in the
transport of cholesterol to the liver. It is now well established
that there is an inverse relationship between the risk of
developing cardiovascular diseases and the concentration of
HDL. However, the protective eﬀect of HDL is not fully
understood. APOAI, the main apolipoprotein of HDL, plays
a critical role in cholesterol eﬄux from macrophages and
foam cells present in the vessel wall [15].
This study investigates genes/proteins implicated in
OxLDL uptake (CD36, SRA), inhibition of cholesterol eﬄux
(ADFP),andinﬂammatoryrecruitmentsofleukocytes(IL-8)
in plaque lesion areas (PLAs) compared to nonplaque lesion
areas (NPLAs) in human carotid endarterectomy samples.
A substantial diﬀerence in mRNA and protein expressions
between PLA and NPLA was observed for CD36, ADFP,
SRA, and IL-8. In addition, a signiﬁcant correlation was
obtained between CD36 expression and ADFP, SRA and IL-
8 in PLA. Moreover, a signiﬁcant inverse correlation was
observed between CD36 gene expression level in PLA and
plasma marker ApoAI.
2. MATERIALS AND METHODS
2.1. Humantissuesamples
Ninety patients, subjected to endarterectomy (carotid steno-
sis >70%) at 3 diﬀerent hospitals (Red Cross Hospital
in Athens (Greece), University Medical Centre in Utrecht
(The Netherlands), and Bichat hospital in Paris (France)),
were enrolled in this study. After removal, endarterectomy
samples were immediately rinsed in RNAse-free sterile PBS,
submerged in RNALater (Ambion, Tex, USA), and stored
at −80◦C. Ethical committees approved the study, and
patients were fully informed and gave their written consent
prior to enrolment. Information concerning the patients is
summarised in Table 1.
2.2. Endarterectomyhandling
The lesions were classiﬁed according to the American Heart
Association (AHA) criteria [16] by expert pathologists
(Table 1). A transverse (perpendicular to the lumen) section
of the internal carotid artery of 5–10μm thickness was taken
in the plaque lesion area (PLA) above the bifurcation point
(Figure 1). When available, a macroscopically nonplaque
lesion area (NPLA) adjacent to the atheromatous area,
removedasapartofthenormalsurgicalprocedure,wasused
as an internal control. The PLA and NPLA sections were
split horizontally giving 2 identical pieces of the same area
being used, respectively, for immunohistochemistry and for
Table 1: Patient phenotypes.
n = 90
Age 66.5 ±8.7
Male/Female 76%/24%
Smokers 64%
Symptoms 56%
Diabetes mellitus 26.8%
Hypertension 84%
Total cholesterol (mM) 4.8 ±0.9
HDl (mM) 1.01 ±0.19
LDL (mM) 3.1 ±0.8
Triglycerides (mM) 3.9 ±2.3
Hematocrit (%) 40 ±4.7
White blood cells (∗10
9/L) 7.3 ±1.4
Platelets (∗10
9/L) 218(115–360)
Glucose (mg/dL) 93 ±27.6
Creatinine (mg/dL) 0.9
beta-blokers 32.8%
calcium antagonists 30.1%
ACE inhibitors 42.5%
Diuretics 29%
ARB 26%
Statins 49%
Aspirin 47.9%
Clopidogrel 46.2%
Insulin 3%
Diabetes mellitus pills 21.9%
ApoAI (mg/dL) 115 ±18
ApoB (mg/dL) 92 ±23
Lp(a) 20 ±48
Histological grade (AHA) 65.7% grade 6
28.6% grade 5
4.3 grade 4
1.4% grade 3
quantitative PCR (Q-PCR) (Figure 1). Fibroatheroma (type
V) or complicated (type VI) lesions, as described in the AHA
criteria constituted the investigated PLA. Both pieces were
washed twice in cold RNAse-free sterile PBS to remove the
RNALater and either included into OCT or immersed into
RLT lysis buﬀer (Qiagen, Calif, USA) to protect the RNA
and stored at −80◦C until further use. For all the samples
includedintoOCT,tissuesectionswerecutat8μmthickness,
dried, and ﬁxed in acetone. Plaque morphology was also
evaluated by staining the tissues with hematoxylin and eosin.
2.3. THP-1cellsculturingandstimulation
Human monocytic leukaemia cell line (THP-1/European
collection of cell cultures-ECACC no. 88081201) was cul-
tured in RPMI 1640 (Sigma, Mo, USA) supplemented
with 10% heat-inactivated foetal calf serum (FCS) (Sigma),
1% glutamine (Sigma), 100μg/mL streptomycin (Sigma)
in a humid incubator with 5% CO2 at 37◦C. THP-1 cells,Sophie Collot-Teixeira et al. 3
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Figure 1: (a) Typical macroscopic pictures of a carotid endarterec-
tomy specimen. (b) A transverse (perpendicular to the lumen)
section of the internal carotid artery was taken in the plaque lesion
area (PLA) above the bifurcation point. (c) A macroscopically
nonplaque area (NPLA) was used as an internal control. The PLA
and the NPLA sections were split horizontally giving 2 identical
pieces that were used, respectively, for immunohistochemistry and
for quantitative PCR.
cultured in 6-well plates at a density 1.2 × 106 cells/well,
were ﬁrst treated with 0.2μM phorbol 12-myristate 13-
acetate (PMA, Sigma) during 24 hours in order to induce the
diﬀerentiation of monocytes into macrophages, then washed
with sterile PBS and stimulated with 100μg/mL oxidised
low-density lipoproteins (OxLDL, Intracell, USA) during
24 hours. Cell viability was evaluated using Trypan blue
counting to be more than 95% for each assay. Stimulation
assays were performed in duplicate and repeated 3 times.
2.4. RNAextraction
THP-1 cells: total RNA extractions were performed using the
RNeasy Mini Kit (Qiagen) following manufacturer’s instruc-
tions. RNA quality and quantity were monitored using a
Nanodropspectrophotometer(NanodropTechnologies,Del,
USA) and an RNA 6000 NanoLabChip kit on a Bioanalyser
(Agilent Technologies, Calif, USA).
Tissue samples: 10 to 30mg of tissue were used for RNA
extraction depending on the tissue size available. Tissues
were ﬁrst cut into very small pieces and homogenised
with 350μL of RLT lysis buﬀer (Qiagen) using a Polytron
(2 × 3 0 so ni c e ) .A f t e r1 0m i n u t e sa t5 5 ◦C proteinase
K step (0.22g/L
−1), the tissue lysate was centrifuged 3
minutes at 10.000g and RNA extraction was performed on
the supernatant following manufacturer’s instructions using
RNeasy Mini Kit (Qiagen). RNA quality and quantity were
monitored using RNA 6000 PicoLabChip/NanoLabChip
kit on a Bioanalyser (Agilent) and using the Nanodrop
spectrophotometer (Nanodrop Technologies). Total RNA
extracted from highly calciﬁed lesions was poor and these
were removed from the cohort.
2.5. Retrotranscription(RT)andreal-time
quantitativePCR(Q-PCR)
Only total RNA extracts presenting good integrity on
Bioanalyser proﬁles were retrotranscribed (1μgf o rT H P -
1 cells or 200ng for tissue samples) with superscript III
reverse transcriptase (Invitrogen) following manufacturer’s
instructions.
Q-PCR assays were carried out using the 7900 HT
Sequence Detector System (Applied Biosystems/Ambion,
(AB)). Five microlitres of 10X RT product were ampliﬁed
using 1X of Universal PCR Master Mix (AB), 1X assay-
on-demand (containing speciﬁc primers and labelled probe,
AB) in a ﬁnal volume of 25μL. Q-PCR ampliﬁcation was
performed in duplicate. 18SrRNA (AB) ampliﬁcation was
used for normalisation. Each gene was assayed individually.
2.6. Immunohistochemistryandquantitative
imageanalysis
Serial sections of endarterectomy samples (NPLA and PLA)
were ﬁrst immunostained with an anti-CD68 (1/500, Dako,
Glostrup, Denmark), an antialpha actin (1/50, Dako), and
an anti-CD31 (1/20, Dako) in order to localise macrophages,
smooth muscle cells (SMCs), and endothelial cells, respec-
tively. Then sections were incubated with either an anti-
CD36 monoclonal antibody (1/25, BioCytex, Marseille,
France), an anti-SRA (1/100, R&D Systems, Minn, USA), an
anti-ADFP (1/200, Chemicon, Millipore, Billerica, USA), or
the corresponding IgG isotype. Staining was visualised using
the Envision kit (Dako). Slides were then counterstained
with hematoxylin and mounted in DPX (Sigma). Staining of
CD36,SRA,andADFPwasquantitativelyanalysedbytheuse
of a colour image analyser (Sight System, Newbury, Berks,
UK; Software by Foster-Finley Associates, Newcastle, UK)
detecting the peroxidase reaction product by measurement
of pixels in terms of hue, saturation, and intensity values.
By this method, the percentage of the stained tissue was
measured. For each tissue, the entire section was analysed
and the intensity staining obtained was normalised via the
surface of the tissue analysed [17, 18].
2.7. Western-blot
Proteins were extracted using 5%-tritonX-100 lysis buﬀer.
Twenty micrograms of total proteins were subjected to
SDS-polyacrylamide gel electrophoresis and transferred to
nitrocellulose membranes. The membranes were incubated
with an anti-CD36 monoclonal antibody (Clone 10/5)
(BioCytex), or with an anti-ADFP polyclonal antibody
(AB9102) (Chemicon) at dilutions 1/100 and 1/2000, respec-
tively. Detection was performed using ECL western blotting
detection reagents (Amersham, Buckinghamshire, UK) and
exposure to Kodak Biomax XAR ﬁlms (Sigma). Signals were
analysed and compared using GelDoc software (BioRad
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Figure 2: Comparison of gene/protein expression patterns between OxLDL-treated (100 μg/mL, for 24 hours) and PBS-treated PMA-
diﬀerentiated THP-1 cells. (a) Real-time quantitative PCR showing gene expression levels for CD36, SRA, adipophilin (ADFP), and IL-8.
(b),(c)Western-blotanalysisof,respectively,CD36andADFPproteinexpressionlevels.(d)IL-8proteinlevelsinTHP-1culturesupernatants
assayed by ELISA. Treated and untreated cells are, respectively, represented by plain and dotted bars. Bars represent the means ± SE for 3
diﬀerent experiments performed in duplicate. Wilcoxon matched pairs test was used to determine signiﬁcance. ∗∗P ≤ .01, ∗P ≤ .05.
2.8. ELISA
IL-8 levels were measured in cell supernatants in duplicate
using an IL-8 ELISA Kit (Quantikine from R&D Systems)
accordingto the supplier’s instructions.
2.9. Statisticalanalysis
Statistical analyses were performed using Wilcoxon matched
pairs tests (ranks test) and Mann-Whitney tests (Statistica
software, Statsoft). Online software (http://www.fon.hum.
uva.nl/Service/Statistics/Correlation coeﬃcient.html)w a s
used to conduct Pearson’s correlation tests. In all cases, a
value of P ≤ .05 was regarded as signiﬁcant.
3. RESULTS
3.1. OxLDLstimulationinPMA-differentiated
THP-1macrophages
An in vitro approach was ﬁrst used to investigate the gene
and protein expressions, under our laboratory conditions,
of 4 OxLDL-targeted genes (CD36, SRA, ADFP, IL-8) prior
to starting the work on endarterectomy tissues. Twenty
four hours of OxLDL treatment (100μg/mL) of PMA-
diﬀerentiated THP-1 macrophages, compared to cells incu-
bated with PBS only, induced a signiﬁcant increase of CD36
(4.1 ± 1.1-fold), IL-8 (3.4 ± 0.9-fold), and ADFP (7.4 ± 1.4-
fold) gene expressions, P<. 05 (Figure 2(a)). In contrast, a
decreaseofSRAgeneexpression(0.5±0.1-fold)wasobserved
in these cells after OxLDL treatment (100μg/mL) P<. 05.
Western-blot analysis showed that CD36 and ADFP protein
levels were also increased respectively by 132% (±30%) (P =
.05) and by 31% (±3%, P = .01) after the OxLDL treatment
(Figures 2(b) and 2(c)). IL-8 increased by 22% (±1.1%, P =
.005) in cell supernatant using ELISA assays (Figure 2(d)).
3.2. Comparisonofgeneandproteinexpressionsin
PLAversusNPLA
Gene and protein expressions (CD36, SRA, ADFP, and IL-8)
at sites of PLA were compared to NPLA in endarterectomy
samples. CD36 (6.80 versus 5.41, P = .0045), ADFP (6.85
versus 5.78, P = .0017), SRA (6.93 versus 6.27, P = .23),
and IL-8 (5.98 versus 4.93, P = .0065) genes were shown
to be signiﬁcantly more expressed in PLA compared to
NPLA in the 15 patient’s samples investigated (Figure 3(a)).
Furthermore, PLA showed signiﬁcantly higher CD36Sophie Collot-Teixeira et al. 5
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Figure 3: Gene and protein expression levels in carotid endarterectomy PLAs (plaque lesion areas) and NPLAs (nonplaque lesion areas).
(a) Real-time quantitative PCR showing gene expression levels for CD36, adipophilin (ADFP), SRA, and IL-8 in carotid endarterectomy
PLA compared to NPLA. (b) Staining of negative isotype, CD68, α-actin, and CD36 proteins in PLA and NPLA and quantitative
immunohistochemistry for CD36 protein expression in PLA versus NPLA. (c) Staining of negative isotype, CD68, α-actin, and ADFP
proteins in PLA and NPLA and quantitative immunohistochemistry for ADFP protein expression in PLA versus NPLA. (d) Staining of
negative isotype, CD68, α-actin, and SRA proteins in PLA and NPLA and quantitative immunohistochemistry for SRA protein expression
in PLA versus NPLA. Wilcoxon matched pairs test was used to determine signiﬁcance. ∗∗P ≤ .001, ∗P ≤ .05; L: lumen; magniﬁcation: 10X.6 Journal of Biomedicine and Biotechnology
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Figure 4 :C o r r e l a t i o no fC D 3 6w i t h( a )S R A( n = 72), (b) adipophilin (n = 88), or (c) IL-8 (n = 88) gene expression in plaque lesion
area (PLA). (d) Correlation of CD36 gene expression in plaque lesion areas (PLAs) with plasma marker ApoAI level in 57 patients. Pearson’s
correlation statistical test was used.
(0.15 versus 0.019, P = .017), ADFP (0.051 versus 0.026,
P = .049), and SRA (0.081 versus 0.027, P = .027)
protein levels compared to NPLA using quantitative
immunostaining techniques in the 8 patient’s samples
investigated (Figures 3(b), 3(c), and 3(d)).
3.3. CorrelationofCD36withSRAorADFPincarotid
endarterectomyspecimens
In PLA samples, a signiﬁcant correlation was observed
between CD36 and SRA mRNA expression levels (n = 72,
R = .767, P<. 01). Interestingly, a signiﬁcant correlation
was also observed between CD36 and ADFP (n = 88, R =
.786, P<. 01) and between CD36 and IL-8 (n = 88, R =
.499, P<. 01) mRNA expression levels (Figure 4).
3.4. CorrelationbetweenCD36withApoAIandHDL
A signiﬁcant inverse correlation was observed between CD36
gene expression level in PLA samples (n = 57) and plasma
marker ApoAI (R = .288, P = .029) (Figure 4(d)). Further-
more, an inverse correlation was also found between CD36
gene expression and HDL plasma level, however it was not
statistically signiﬁcant (R = .207, P = .1). No correlation
was observed between CD36 and total cholesterol, LDL,
triglycerides, plasma ApoB, medication, smoking status or
gender (data not shown).
4. DISCUSSION
In this study, a substantial diﬀerence in mRNA and protein
expressions was observed for CD36 and molecules impli-
cated in lipid metabolism (ADFP, SRA) and inﬂammation
(IL-8) between plaque lesion area (PLA) and nonplaque
lesion area (NPLA) in human carotid endarterectomies.
Moreover,resultsobtainedforaninvitromacrophagemodel
(PMA-treated THP-1 cells) stimulated by OxLDL show a
trend, with the exception of SRA, that is similar to those
obtained in PLA. In addition, a signiﬁcant correlation was
obtained between CD36 expression and ADFP, SRA, and IL-
8 in PLA. Furthermore, a signiﬁcant inverse correlation was
observed between CD36 gene expression level in PLA and
plasma marker ApoAI.
CD36, ADFP, and SRA are strongly correlated in this
study in PLA and are potentially proatherogenic proteins.
Indeed, resident vascular macrophages have scavenger recep-
tors CD36 and SRA that play a key role in the uptake of
OxLDL. Moreover, ADFP in these very same macrophages
is involved in lipid accumulation by inhibiting eﬄux [12]. It
has also been described that the ABCA1 transporter protein
expression, involved in the cholesterol transport from cells
to apolipoproteins in plasma, was signiﬁcantly reduced in
carotid lesions compared with controls tissues [19]. The
uptake of OxLDL upregulates scavenger receptors and the
adipophilin expression and ensures the formation of foam
cells and the perpetuation of lesions. An inﬂammatorySophie Collot-Teixeira et al. 7
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Figure 5: Hypothetical representation of OxLDL inﬂux and inhibition of cholesterol eﬄux in carotid resident macrophages. In the presence
ofhighexpressionofCD36inplaquelesionareas,theobservedstrongcorrelationbetweenCD36,SRA,andADFPsuggeststhatcarotidlesion
resident macrophages are subjected on the one hand to greatly enhanced OxLDL uptake by CD36 and SRA and on the other to inhibition
of cholesterol eﬄux by ADFP. The cholesterol eﬄux from resident macrophages is probably even further reduced as indicated by the inverse
correlation of CD36 expression with plasma cholesterol acceptor ApoAI.
component (IL-8) that is correlated to CD36 in PLA is also
observed. This brings a further dimension to the capacity
of resident macrophages to attract further monocytes to
the sites of inﬂammation through the release of IL-8. An
additional interesting ﬁnding in this study is that the plasma
acceptor ApoAI, a constituent of HDL, needed for trans-
portation of cholesterol from macrophages is signiﬁcantly
inversely correlated to CD36 gene expression level in PLA.
Macrophages do not synthesise ApoAI and need to have it
readily available in plasma as a cholesterol acceptor. In the
absence of ApoAI, cholesterol eﬄux is greatly reduced. HDL
levels were also inversely correlated to CD36 gene expression
but this correlation did not reach statistical signiﬁcance.
CD36 in this study is statistically more highly expressed
in PLA (grade V and VI lesions, AHA classiﬁcations) [16]
compared to NPLA regions. Cells expressing CD36 are
mostly macrophages as indicated by CD68 labelling. CD36
in murine ApoE
−/− macrophages, compared to ApoE
−/−
CD36
−/−, has been shown in several studies to be linked
to the generation of atherosclerotic lesions. However, a
certain caution needs to be taken in trying to understand
human atherosclerotic lesions compared to those generated
in ApoE
−/− mice. Indeed, in the ApoE
−/− murine model of
atherosclerosis there is an absence of myocardial infarction
or stroke that are the results of clinical complications
of atherosclerosis in patients. The intense CD36 labelling
obtained in this study for PLA compared to NPLA suggests
that this scavenger receptor is actively involved in the
perpetuation of lesions in human vessels.
The PMA-diﬀerentiated THP-1 incubated with OxLDL
showed a similar upregulation of CD36, ADFP, and IL-8
gene and protein expressions compared to those obtained
in PLA versus NPLA. In contrast, SRA which is enhanced
in PLA versus NPLA was shown to be decreased by OxLDL
treatment in PMA-diﬀerentiated THP-1. It is conceivable
that SRA and CD36 might be regulated diﬀerentially and
therefore could play diﬀerent roles in the formation of foam
cells in atherosclerotic lesions. Indeed, CD36 and SRA are
diﬀerently expressed in lesion area present in post-mortem
descending human thoracic aorta [20]. Alternatively, a
monocytic cell line such as THP-1 cells may diﬀer in its
response from normal monocytes/macrophages.
A certain caution needs to be taken in interpreting
the above data. However, an interesting working hypothesis
would rely on carotid resident macrophages to take up
OxLDL via upregulated CD36 and SRA and inhibit choles-
terol eﬄuxasaresultofthehighexpressionofADFPandlow
levels of plasma cholesterol acceptor ApoAI. Moreover, IL-8
would be implicated in monocyte recruitment to the sites of
inﬂammation (Figure 5).
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